Atacurium

Category:

  • Muscle relaxant

Description:

  • Nondepolarizing skeletal muscle relaxant

Indications:

  • Adjunct to general anesthesia to facilitate intubation and skeletal muscle relaxation

Contraindications:

Precautions:

  • Pregnancy category C

  • Only used by skilled personnel in airway management and respiratory support.

  • Must have anticholinesterase reversal agents immediately available during use.

  • Will cause histamine release.  Use with caution in patients susceptible to histamine, such as cardiovascular disease and asthma.

  • Contains benzyl alcohol that may cause “gasping syndrome” in premature infants.

  • May cause bradycardia during anesthesia.

  • Use with caution in patients with neuromuscular disease.

  • May cause malignant hyperthermia in susceptible patients.

  • Use a peripheral nerve stimulator to monitor twitch suppression and recovery.

  • IM injection may cause tissue irritation.

Adverse Reactions (Side Effects):

  • Cardiovascular: hypotension (up to 14%), vasodilation (up to 9%), tachycardia (up to 5%), bradycardia

  • Dermatologic: rash, urticaria, injection-site reactions

  • Respiratory: dyspnea, broncho- and laryngospasm

 

Dosage:

  • Administered via IV injection (IM may cause tissue irritation)

  • Bolus:

    • Initial adult dose: 0.4-0.5mg/kg IV bolus

    • Maintenance adult dose: 0.08-0.1mg/kg every 15-25 minutes to maintain blockade

  • Pediatric dose:

    • Children > 2 years old: no adjustments needed

    • Children 1 month – 2 years old: 0.3-0.4mg/kg

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

Advertise on this site